Early administration of verapamil after thrombolysis in acute anterior myocardial infarction. Effect on left ventricular remodeling and clinical outcome

V. Marangelli, C. Memmola, M. S. Brigiani, L. Boni, M. G. Biasco, D. Scrutinio, S. Iliceto, P. Rizzon

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background. The administration of verapamil during the reperfusion phase of acute myocardial infarction can reduce the extent and severity of microvessel damage and limit myocardial dysfunction. We aimed at investigating the effect of early verapamil administration on left ventricular remodeling and the clinical evolution after myocardial infarction. Methods. Eighty-eight patients with first acute anterior myocardial infarction thrombolysed <4 hours from symptom onset were enrolled in a multicenter, randomized, double-blind, controlled study of verapamil administration (5 mg i.v. + 2 μg/kg/min over 24 hours). Echocardiographic end-diastolic (EDV) and end-systolic (ESV) left ventricular volumes were assessed by biplane Simpson's rule. Results. At 90 days, EDV in the verapamil and placebo groups was respectively 88.9 ± 27.8 and 95.8 ± 30.7 ml (p = 0.11), ESV was 52.6 ± 22.7 and 57.7 ± 25.4 ml (p = 0.18). There was no change over time in the verapamil group (day 3 vs day 90: EDV 85.0 ± 17.7 vs 88.9 ± 27.8 ml, p = NS; ESV 48.7 ± 14.1 vs 52.6 ± 22.7 ml, p = NS) while left ventricular volume increased in the placebo group (day 3 vs day 90: EDV 87.6 ± 21.1 vs 95.8 ± 30.7 ml, p = 0.03; ESV 52.0 ± 16.9 vs 57.7 ± 25.4 ml, p = 0.08). NYHA functional classes were differently distributed at 30 and 90 days (χ2 = 0.009 and 0.07), with a lower prevalence of classes II and III in the verapamil group (p = 0.03). Conclusions. The early intravenous administration of verapamil in thrombolysed patients can reduce left ventricular remodeling and NYHA functional class after acute anterior myocardial infarction.

Original languageEnglish
Pages (from-to)336-343
Number of pages8
JournalItalian Heart Journal
Volume1
Issue number5
Publication statusPublished - 2000

Fingerprint

Ventricular Remodeling
Verapamil
Myocardial Infarction
Placebos
Microvessels
Double-Blind Method
Intravenous Administration
Reperfusion

Keywords

  • Controlled clinical trials
  • Myocardial infarction
  • Remodeling, left ventricular
  • Thrombolytic therapy
  • Verapamil

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Early administration of verapamil after thrombolysis in acute anterior myocardial infarction. Effect on left ventricular remodeling and clinical outcome. / Marangelli, V.; Memmola, C.; Brigiani, M. S.; Boni, L.; Biasco, M. G.; Scrutinio, D.; Iliceto, S.; Rizzon, P.

In: Italian Heart Journal, Vol. 1, No. 5, 2000, p. 336-343.

Research output: Contribution to journalArticle

Marangelli, V. ; Memmola, C. ; Brigiani, M. S. ; Boni, L. ; Biasco, M. G. ; Scrutinio, D. ; Iliceto, S. ; Rizzon, P. / Early administration of verapamil after thrombolysis in acute anterior myocardial infarction. Effect on left ventricular remodeling and clinical outcome. In: Italian Heart Journal. 2000 ; Vol. 1, No. 5. pp. 336-343.
@article{5d99a53b69a54e5aaeac3d733285b547,
title = "Early administration of verapamil after thrombolysis in acute anterior myocardial infarction. Effect on left ventricular remodeling and clinical outcome",
abstract = "Background. The administration of verapamil during the reperfusion phase of acute myocardial infarction can reduce the extent and severity of microvessel damage and limit myocardial dysfunction. We aimed at investigating the effect of early verapamil administration on left ventricular remodeling and the clinical evolution after myocardial infarction. Methods. Eighty-eight patients with first acute anterior myocardial infarction thrombolysed <4 hours from symptom onset were enrolled in a multicenter, randomized, double-blind, controlled study of verapamil administration (5 mg i.v. + 2 μg/kg/min over 24 hours). Echocardiographic end-diastolic (EDV) and end-systolic (ESV) left ventricular volumes were assessed by biplane Simpson's rule. Results. At 90 days, EDV in the verapamil and placebo groups was respectively 88.9 ± 27.8 and 95.8 ± 30.7 ml (p = 0.11), ESV was 52.6 ± 22.7 and 57.7 ± 25.4 ml (p = 0.18). There was no change over time in the verapamil group (day 3 vs day 90: EDV 85.0 ± 17.7 vs 88.9 ± 27.8 ml, p = NS; ESV 48.7 ± 14.1 vs 52.6 ± 22.7 ml, p = NS) while left ventricular volume increased in the placebo group (day 3 vs day 90: EDV 87.6 ± 21.1 vs 95.8 ± 30.7 ml, p = 0.03; ESV 52.0 ± 16.9 vs 57.7 ± 25.4 ml, p = 0.08). NYHA functional classes were differently distributed at 30 and 90 days (χ2 = 0.009 and 0.07), with a lower prevalence of classes II and III in the verapamil group (p = 0.03). Conclusions. The early intravenous administration of verapamil in thrombolysed patients can reduce left ventricular remodeling and NYHA functional class after acute anterior myocardial infarction.",
keywords = "Controlled clinical trials, Myocardial infarction, Remodeling, left ventricular, Thrombolytic therapy, Verapamil",
author = "V. Marangelli and C. Memmola and Brigiani, {M. S.} and L. Boni and Biasco, {M. G.} and D. Scrutinio and S. Iliceto and P. Rizzon",
year = "2000",
language = "English",
volume = "1",
pages = "336--343",
journal = "Italian Heart Journal",
issn = "1129-471X",
publisher = "Societa Italiana di Cardiologia",
number = "5",

}

TY - JOUR

T1 - Early administration of verapamil after thrombolysis in acute anterior myocardial infarction. Effect on left ventricular remodeling and clinical outcome

AU - Marangelli, V.

AU - Memmola, C.

AU - Brigiani, M. S.

AU - Boni, L.

AU - Biasco, M. G.

AU - Scrutinio, D.

AU - Iliceto, S.

AU - Rizzon, P.

PY - 2000

Y1 - 2000

N2 - Background. The administration of verapamil during the reperfusion phase of acute myocardial infarction can reduce the extent and severity of microvessel damage and limit myocardial dysfunction. We aimed at investigating the effect of early verapamil administration on left ventricular remodeling and the clinical evolution after myocardial infarction. Methods. Eighty-eight patients with first acute anterior myocardial infarction thrombolysed <4 hours from symptom onset were enrolled in a multicenter, randomized, double-blind, controlled study of verapamil administration (5 mg i.v. + 2 μg/kg/min over 24 hours). Echocardiographic end-diastolic (EDV) and end-systolic (ESV) left ventricular volumes were assessed by biplane Simpson's rule. Results. At 90 days, EDV in the verapamil and placebo groups was respectively 88.9 ± 27.8 and 95.8 ± 30.7 ml (p = 0.11), ESV was 52.6 ± 22.7 and 57.7 ± 25.4 ml (p = 0.18). There was no change over time in the verapamil group (day 3 vs day 90: EDV 85.0 ± 17.7 vs 88.9 ± 27.8 ml, p = NS; ESV 48.7 ± 14.1 vs 52.6 ± 22.7 ml, p = NS) while left ventricular volume increased in the placebo group (day 3 vs day 90: EDV 87.6 ± 21.1 vs 95.8 ± 30.7 ml, p = 0.03; ESV 52.0 ± 16.9 vs 57.7 ± 25.4 ml, p = 0.08). NYHA functional classes were differently distributed at 30 and 90 days (χ2 = 0.009 and 0.07), with a lower prevalence of classes II and III in the verapamil group (p = 0.03). Conclusions. The early intravenous administration of verapamil in thrombolysed patients can reduce left ventricular remodeling and NYHA functional class after acute anterior myocardial infarction.

AB - Background. The administration of verapamil during the reperfusion phase of acute myocardial infarction can reduce the extent and severity of microvessel damage and limit myocardial dysfunction. We aimed at investigating the effect of early verapamil administration on left ventricular remodeling and the clinical evolution after myocardial infarction. Methods. Eighty-eight patients with first acute anterior myocardial infarction thrombolysed <4 hours from symptom onset were enrolled in a multicenter, randomized, double-blind, controlled study of verapamil administration (5 mg i.v. + 2 μg/kg/min over 24 hours). Echocardiographic end-diastolic (EDV) and end-systolic (ESV) left ventricular volumes were assessed by biplane Simpson's rule. Results. At 90 days, EDV in the verapamil and placebo groups was respectively 88.9 ± 27.8 and 95.8 ± 30.7 ml (p = 0.11), ESV was 52.6 ± 22.7 and 57.7 ± 25.4 ml (p = 0.18). There was no change over time in the verapamil group (day 3 vs day 90: EDV 85.0 ± 17.7 vs 88.9 ± 27.8 ml, p = NS; ESV 48.7 ± 14.1 vs 52.6 ± 22.7 ml, p = NS) while left ventricular volume increased in the placebo group (day 3 vs day 90: EDV 87.6 ± 21.1 vs 95.8 ± 30.7 ml, p = 0.03; ESV 52.0 ± 16.9 vs 57.7 ± 25.4 ml, p = 0.08). NYHA functional classes were differently distributed at 30 and 90 days (χ2 = 0.009 and 0.07), with a lower prevalence of classes II and III in the verapamil group (p = 0.03). Conclusions. The early intravenous administration of verapamil in thrombolysed patients can reduce left ventricular remodeling and NYHA functional class after acute anterior myocardial infarction.

KW - Controlled clinical trials

KW - Myocardial infarction

KW - Remodeling, left ventricular

KW - Thrombolytic therapy

KW - Verapamil

UR - http://www.scopus.com/inward/record.url?scp=0033834851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033834851&partnerID=8YFLogxK

M3 - Article

C2 - 10832809

AN - SCOPUS:0033834851

VL - 1

SP - 336

EP - 343

JO - Italian Heart Journal

JF - Italian Heart Journal

SN - 1129-471X

IS - 5

ER -